CTA
ABBV icon

Carillon Tower Advisers’s AbbVie ABBV Stock Holding History

Carillon Tower Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$21.2M Buy
197,753
+119,353
+152% +$11.5M 0.13% 231
2020
Q3 		$6.87M Buy
78,400
+11,400
+17% +$1.07M 0.09% 298
2020
Q2 		$6.58M Sell
67,000
-4,400
-6% -$387K 0.05% 345
2020
Q1 		$5.44M Sell
71,400
-11,400
-14% -$971K 0.05% 334
2019
Q4 		$7.33M Sell
82,800
-6,000
-7% -$498K 0.05% 362
2019
Q3 		$6.72M Buy
88,800
+21,100
+31% +$1.45M 0.05% 371
2019
Q2 		$4.92M Hold
67,700
– – 0.03% 390
2019
Q1 		$5.46M Buy
+67,700
New +$5.54M 0.04% 380
2018
Q3 		– Sell
-73,100
Closed -$6.77M – 420
2018
Q2 		$6.77M Buy
+73,100
New +$7.14M 0.05% 358

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Carillon Tower Advisers's ABBV Position: Q4 2020 in Review

Carillon Tower Advisers increased its AbbVie (ABBV) stake by 152% in Q4 2020, buying an estimated $11.5M and bringing the position to 197,753 shares worth $21.2M. The position accounts for 0.13% of the portfolio, ranked #231.

Carillon Tower Advisers first reported a position in ABBV in Q2 2018 and has held it in 9 quarters since. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Carillon Tower Advisers held 197,753 shares of AbbVie worth $21.2M as of Q4 2020.
  • Carillon Tower Advisers bought 119,353 AbbVie shares in Q4 2020, an estimated $11.5M.
  • AbbVie made up 0.13% of Carillon Tower Advisers's portfolio in Q4 2020, its #231 holding.
  • Carillon Tower Advisers first reported a position in AbbVie in Q2 2018 and has held it in 9 quarters since.
  • 2,599 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.